Chemical Name: | 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(1-ethyltetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate |
CAS Number: | 914613-35-7 |
Product Number: | AG006MAO(AGN-PC-0CM31T) |
Synonyms: | |
MDL No: | |
Molecular Formula: | C35H38N6O6 |
Molecular Weight: | 638.7128 |
1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2′-(1-ethyl-1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylate is a versatile compound used in chemical synthesis as a key building block for designing novel pharmaceutical agents. This compound serves as a strategic intermediate, providing functional groups for further modification to enhance the bioactivity and pharmacological properties of the final products. Its unique structure combines the flexibility of an ethyl ester linkage with the rigidity of a benzimidazole core, offering opportunities for structure-activity relationship studies and structure-based drug design. In the realm of medicinal chemistry, this compound plays a crucial role in the development of potential drug candidates targeting specific biological pathways or disease mechanisms. Its ability to undergo selective transformations allows for the synthesis of diverse analogs with improved potency, selectivity, and pharmacokinetic profiles.